<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37482930</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>The role of peripheral immunity in ALS: a population-based study.</ArticleTitle><Pagination><StartPage>1623</StartPage><EndPage>1632</EndPage><MedlinePgn>1623-1632</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51853</ELocationID><Abstract><AbstractText Label="BACKGROUND">Systemic inflammation has been proposed as a relevant mechanism in amyotrophic lateral sclerosis (ALS). Still, comprehensive data on ALS patients' innate and adaptive immune responses and their effect on the clinical phenotype are lacking. Here, we investigate systemic immunity in a population-based ALS cohort using readily available hematological indexes.</AbstractText><AbstractText Label="METHODS">We collected clinical data and the complete blood count (CBC) at diagnosis in ALS patients from the Piemonte and Valle d'Aosta Register for ALS (PARALS) from 2007 to 2019. Leukocytes populations, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic-immune-inflammation index (SII), and lymphocyte-to-monocyte ratio (LMR) were derived from CBC. All variables were analyzed for association with clinical features in the entire cohort and then in sex- and age-based subgroups.</AbstractText><AbstractText Label="RESULTS">Neutrophils (P&#x2009;=&#x2009;0.001) and markers of increased innate immunity (NLR, P&#x2009;=&#x2009;0.008 and SII, P&#x2009;=&#x2009;0.006) were associated with a faster disease progression. Similarly, elevated innate immunity correlated with worse pulmonary function and shorter survival. The prognosis in women also correlated with low lymphocytes (P&#x2009;=&#x2009;0.045) and a decreased LMR (P&#x2009;=&#x2009;0.013). ALS patients with cognitive impairment exhibited lower monocytes (P&#x2009;=&#x2009;0.0415).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">The dysregulation of the systemic immune system plays a multifaceted role in ALS. More specifically, an elevated innate immune response is associated with faster progression and reduced survival. Conversely, ALS patients with cognitive impairment showed a reduction in monocyte count. Additionally, immune response varied according to sex and age, thus suggesting that involved immune pathways are patient specific. Further studies will help translate those findings into clinical practice or targeted treatments.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Grassano</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6714-6897</Identifier><AffiliationInfo><Affiliation>ALS Centre, Department of Neuroscience "Rita Levi Montalcini", University of Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Manera</LastName><ForeName>Umberto</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>ALS Centre, Department of Neuroscience "Rita Levi Montalcini", University of Torino, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SC Neurologia 1U, AOU Citt&#xe0; della Salute e della Scienza of Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Marchi</LastName><ForeName>Fabiola</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology and ALS Centre, University of Piemonte Orientale, Maggiore della Carit&#xe0; Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cugnasco</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>ALS Centre, Department of Neuroscience "Rita Levi Montalcini", University of Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matteoni</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>ALS Centre, Department of Neuroscience "Rita Levi Montalcini", University of Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daviddi</LastName><ForeName>Margherita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ALS Centre, Department of Neuroscience "Rita Levi Montalcini", University of Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solero</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>ALS Centre, Department of Neuroscience "Rita Levi Montalcini", University of Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bombaci</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ALS Centre, Department of Neuroscience "Rita Levi Montalcini", University of Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palumbo</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>ALS Centre, Department of Neuroscience "Rita Levi Montalcini", University of Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasta</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>ALS Centre, Department of Neuroscience "Rita Levi Montalcini", University of Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canosa</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ALS Centre, Department of Neuroscience "Rita Levi Montalcini", University of Torino, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SC Neurologia 1U, AOU Citt&#xe0; della Salute e della Scienza of Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salamone</LastName><ForeName>Paolina</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>ALS Centre, Department of Neuroscience "Rita Levi Montalcini", University of Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuda</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>ALS Centre, Department of Neuroscience "Rita Levi Montalcini", University of Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casale</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>ALS Centre, Department of Neuroscience "Rita Levi Montalcini", University of Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzini</LastName><ForeName>Letizia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology and ALS Centre, University of Piemonte Orientale, Maggiore della Carit&#xe0; Hospital, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Calvo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5122-7243</Identifier><AffiliationInfo><Affiliation>ALS Centre, Department of Neuroscience "Rita Levi Montalcini", University of Torino, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SC Neurologia 1U, AOU Citt&#xe0; della Salute e della Scienza of Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Moglia</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ALS Centre, Department of Neuroscience "Rita Levi Montalcini", University of Torino, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SC Neurologia 1U, AOU Citt&#xe0; della Salute e della Scienza of Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chi&#xf2;</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ALS Centre, Department of Neuroscience "Rita Levi Montalcini", University of Torino, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SC Neurologia 1U, AOU Citt&#xe0; della Salute e della Scienza of Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001772" MajorTopicYN="N">Blood Cell Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007962" MajorTopicYN="N">Leukocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Maurizio Grassano, Umberto Manera, Fabiola De Marchi, Paolo Cugnasco, Enrico Matteoni, Margherita Daviddi, Luca Solero, Alessandro Bombaci, Francesca Palumbo, Rosario Vasta, Antonio Canosa, Paolina Salamone, Giuseppe Fuda, Federico Casale, Letizia Mazzini, Cristina Moglia report nothing to disclose. Andrea Calvo has received a research grant from Cytokinetics. Adriano Chi&#xf2; serves on scientific advisory boards for Mitsubishi Tanabe, Roche, Denali Pharma, Cytokinetics, and Amylyx.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>3</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37482930</ArticleId><ArticleId IdType="pmc">PMC10502618</ArticleId><ArticleId IdType="doi">10.1002/acn3.51853</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lyon MS, Wosiski&#x2010;Kuhn M, Gillespie R, Caress J, Milligan C. Inflammation, immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology: inflammation, immunity, and ALS: I. Muscle Nerve. 2019;59(1):10&#x2010;22. doi:10.1002/mus.26289</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26289</ArticleId><ArticleId IdType="pubmed">29979464</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Gascon R, Miller RG, et&#xa0;al. Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol. 2005;159(1&#x2013;2):215&#x2010;224. doi:10.1016/j.jneuroim.2004.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2004.10.009</ArticleId><ArticleId IdType="pubmed">15652422</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani S, Garbelli S, Pasini A, et&#xa0;al. Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process. J Neuroimmunol. 2009;210(1&#x2013;2):73&#x2010;79. doi:10.1016/j.jneuroim.2009.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2009.02.012</ArticleId><ArticleId IdType="pubmed">19307024</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Bender DE, Kashlan SR, et&#xa0;al. Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm. 2016;3(4):e242. doi:10.1212/NXI.0000000000000242</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000242</ArticleId><ArticleId IdType="pmc">PMC4897983</ArticleId><ArticleId IdType="pubmed">27308304</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Zhou T, Kashlan SR, Little RJ, Goutman SA, Feldman EL. Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression. JAMA Neurol. 2017;74(12):1446. doi:10.1001/jamaneurol.2017.2255</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.2255</ArticleId><ArticleId IdType="pmc">PMC5822195</ArticleId><ArticleId IdType="pubmed">28973548</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivier E, Raulet DH, Moretta A, et&#xa0;al. Innate or adaptive immunity? The example of natural killer cells. Science. 2011;331(6013):44&#x2010;49. doi:10.1126/science.1198687</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1198687</ArticleId><ArticleId IdType="pmc">PMC3089969</ArticleId><ArticleId IdType="pubmed">21212348</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivier E, Artis D, Colonna M, et&#xa0;al. Innate lymphoid cells: 10&#x2009;years on. Cell. 2018;174(5):1054&#x2010;1066. doi:10.1016/j.cell.2018.07.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.07.017</ArticleId><ArticleId IdType="pubmed">30142344</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Yang XR, Xu Y, et&#xa0;al. Systemic immune&#x2010;inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212&#x2010;6222. doi:10.1158/1078-0432.CCR-14-0442</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-14-0442</ArticleId><ArticleId IdType="pubmed">25271081</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xf8;st TH, Alcala K, Urbarova I, et&#xa0;al. Systemic inflammation markers and cancer incidence in the UK biobank. Eur J Epidemiol. 2021;36(8):841&#x2010;848. doi:10.1007/s10654-021-00752-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-021-00752-6</ArticleId><ArticleId IdType="pmc">PMC8416852</ArticleId><ArticleId IdType="pubmed">34036468</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SJ, Hong YH, Kim SM, Shin JY, Suh YJ, Sung JJ. High neutrophil&#x2010;to&#x2010;lymphocyte ratio predicts short survival duration in amyotrophic lateral sclerosis. Sci Rep. 2020;10(1):428. doi:10.1038/s41598-019-57366-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-57366-y</ArticleId><ArticleId IdType="pmc">PMC6965090</ArticleId><ArticleId IdType="pubmed">31949271</ArticleId></ArticleIdList></Reference><Reference><Citation>Leone MA, Mandrioli J, Russo S, et&#xa0;al. Neutrophils&#x2010;to&#x2010;lymphocyte ratio is associated with progression and overall survival in amyotrophic lateral sclerosis. Biomedicine. 2022;10(2):354. doi:10.3390/biomedicines10020354</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10020354</ArticleId><ArticleId IdType="pmc">PMC8962424</ArticleId><ArticleId IdType="pubmed">35203564</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei QQ, Hou YB, Zhang LY, et&#xa0;al. Neutrophil&#x2010;to&#x2010;lymphocyte ratio in sporadic amyotrophic lateral sclerosis. Neural Regen Res. 2022;17(4):875&#x2010;880. doi:10.4103/1673-5374.322476</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.322476</ArticleId><ArticleId IdType="pmc">PMC8530123</ArticleId><ArticleId IdType="pubmed">34472488</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafson MP, Staff NP, Bornschlegl S, et&#xa0;al. Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis. PLoS One. 2017;12(7):e0182002. doi:10.1371/journal.pone.0182002</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0182002</ArticleId><ArticleId IdType="pmc">PMC5526569</ArticleId><ArticleId IdType="pubmed">28742871</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentzos M, Evangelopoulos E, Sereti E, et&#xa0;al. Alterations of T cell subsets in ALS: a systemic immune activation?: T cell subsets in ALS. Acta Neurol Scand. 2012;125(4):260&#x2010;264. doi:10.1111/j.1600-0404.2011.01528.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2011.01528.x</ArticleId><ArticleId IdType="pubmed">21651502</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Feng W, Huang R, et&#xa0;al. Evidence for peripheral immune activation in amyotrophic lateral sclerosis. J Neurol Sci. 2014;347(1&#x2013;2):90&#x2010;95. doi:10.1016/j.jns.2014.09.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.09.025</ArticleId><ArticleId IdType="pubmed">25312013</ArticleId></ArticleIdList></Reference><Reference><Citation>Provinciali L, Laurenzi MA, Vesprini L, et&#xa0;al. Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets. Acta Neurol Scand. 1988;78(6):449&#x2010;454. doi:10.1111/j.1600-0404.1988.tb03686.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1988.tb03686.x</ArticleId><ArticleId IdType="pubmed">3265563</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol. 2017;35(1):441&#x2010;468. doi:10.1146/annurev-immunol-051116-052358</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-051116-052358</ArticleId><ArticleId IdType="pmc">PMC8167938</ArticleId><ArticleId IdType="pubmed">28226226</ArticleId></ArticleIdList></Reference><Reference><Citation>Zondler L, M&#xfc;ller K, Khalaji S, et&#xa0;al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132(3):391&#x2010;411. doi:10.1007/s00401-016-1548-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1548-y</ArticleId><ArticleId IdType="pubmed">26910103</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Goutman SA, Boss J, Kim S, Feldman EL. Amyotrophic lateral sclerosis survival associates with neutrophils in a sex&#x2010;specific manner. Neurol Neuroimmunol Neuroinflamm. 2021;8(2):e953. doi:10.1212/NXI.0000000000000953</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000953</ArticleId><ArticleId IdType="pmc">PMC8057067</ArticleId><ArticleId IdType="pubmed">33531377</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Moglia C, Canosa A, et&#xa0;al. ALS phenotype is influenced by age, sex, and genetics: a population&#x2010;based study. Neurology. 2020;94(8):e802&#x2010;e810. doi:10.1212/WNL.0000000000008869</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008869</ArticleId><ArticleId IdType="pubmed">31907290</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdani S, Seitz C, Cui C, et&#xa0;al. T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression. Nat Commun. 2022;13(1):6733. doi:10.1038/s41467-022-34526-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34526-9</ArticleId><ArticleId IdType="pmc">PMC9643478</ArticleId><ArticleId IdType="pubmed">36347843</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui C, Ingre C, Yin L, et&#xa0;al. Correlation between leukocyte phenotypes and prognosis of amyotrophic lateral sclerosis. Elife. 2022;11:e74065. doi:10.7554/eLife.74065</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.74065</ArticleId><ArticleId IdType="pmc">PMC8923665</ArticleId><ArticleId IdType="pubmed">35287794</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Appel SH. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol. 2019;18(2):211&#x2010;220. doi:10.1016/S1474-4422(18)30394-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30394-6</ArticleId><ArticleId IdType="pubmed">30663610</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M, G&#xfc;nther R, Akg&#xfc;n K, Hermann A, Ziemssen T. Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis. Sci Rep. 2020;10(1):5941. doi:10.1038/s41598-020-62756-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62756-8</ArticleId><ArticleId IdType="pmc">PMC7125229</ArticleId><ArticleId IdType="pubmed">32246039</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, Siddiqui S, Gabriely G, et&#xa0;al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest. 2012;122(9):3063&#x2010;3087. doi:10.1172/JCI62636</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI62636</ArticleId><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova&#x2010;Davis S, Sanberg PR. Blood&#x2010;CNS barrier impairment in ALS patients versus an animal model. Front Cell Neurosci. 2014;8:21. doi:10.3389/fncel.2014.00021</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00021</ArticleId><ArticleId IdType="pmc">PMC3910123</ArticleId><ArticleId IdType="pubmed">24550780</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X, Coull B, Lin X, et&#xa0;al. Association of neutrophil to lymphocyte ratio with pulmonary function in a 30&#x2010;year longitudinal study of US veterans. JAMA Netw Open. 2020;3(7):e2010350. doi:10.1001/jamanetworkopen.2020.10350</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.10350</ArticleId><ArticleId IdType="pmc">PMC7358911</ArticleId><ArticleId IdType="pubmed">32658288</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X, Colicino E, Shen J, et&#xa0;al. Impacts of air pollution, temperature, and relative humidity on leukocyte distribution: an epigenetic perspective. Environ Int. 2019;126:395&#x2010;405. doi:10.1016/j.envint.2019.02.053</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envint.2019.02.053</ArticleId><ArticleId IdType="pmc">PMC6441628</ArticleId><ArticleId IdType="pubmed">30826618</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>